This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more ...

CHICAGO >> Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

AstraZeneca Plc’s experimental breast cancer pill delayed disease progression by over six months, according to data from a ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

AstraZeneca has unveiled positive trial results for a breast cancer drug that can stop mutating tumours before they start to grow, hoping it will be one of a portfolio of medicines that will propel it ...

Drugs that boost the body's immune system to fight disease are showing promise in treating a variety of cancers in earlier ...

AstraZeneca’s immunotherapy Imfinzi has proven it can help certain patients with early-stage stomach cancer, according to ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

AstraZeneca India Pharma on Thursday said it has received approval from the Central Drugs Standard Control Organisation ...

AstraZeneca's new breast cancer pill, Camizestrant, shows promising results. The drug delayed cancer progression by over six ...